# Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)

> **NCT03366207** · PHASE4 · COMPLETED · sponsor: **Iterum Therapeutics, International Limited** · enrollment: 250 (actual)

## Conditions studied

- UTI - Lower Urinary Tract Infection
- Antibiotic Resistant Infection

## Interventions

- **DRUG:** Ciprofloxacin

## Key facts

- **NCT ID:** NCT03366207
- **Lead sponsor:** Iterum Therapeutics, International Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-15
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-10-26
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03366207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03366207, "Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03366207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*